McMahon N, Jones J, Anderson A, Dietz M, Wong M, Gibbs S. Flexible Cyclic Immunofluorescence (cyCIF) Using Oligonucleotide Barcoded Antibodies. Cancers (Basel). 2023;15: pubmed publisher

Haensel D, Gaddam S, Li N, Gonzalez F, Patel T, Cloutier J, et al. LY6D marks pre-existing resistant basosquamous tumor subpopulations. Nat Commun. 2022;13:7520 pubmed publisher

Johnson B, Creason A, Stommel J, Keck J, Parmar S, Betts C, et al. An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer. Cell Rep Med. 2022;3:100525 pubmed publisher

Shalabi S, Miyano M, Sayaman R, Lopez J, Jokela T, Todhunter M, et al. Evidence for accelerated aging in mammary epithelia of women carrying germline BRCA1 or BRCA2 mutations. Nat Aging. 2021;1:838-849 pubmed publisher

Burlingame E, Eng J, Thibault G, Chin K, Gray J, Chang Y. Toward reproducible, scalable, and robust data analysis across multiplex tissue imaging platforms. Cell Rep Methods. 2021;1: pubmed publisher

Li Z, Hu J, Qin Z, Tao Y, Lai Z, Wang Q, et al. High-dimensional single-cell proteomics analysis reveals the landscape of immune cells and stem-like cells in renal tumors. J Clin Lab Anal. 2020;34:e23155 pubmed publisher

Risom T, Wang X, Liang J, Zhang X, Pelz C, Campbell L, et al. Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneity. J Clin Invest. 2020;130:231-246 pubmed publisher

Nishikata T, Ishikawa M, Matsuyama T, Takamatsu K, Fukuhara T, Konishi Y. Primary culture of breast cancer: a model system for epithelial-mesenchymal transition and cancer stem cells. Anticancer Res. 2013;33:2867-73 pubmed

Rohena C, Peng J, Johnson T, Crews P, Mooberry S. Chemically diverse microtubule stabilizing agents initiate distinct mitotic defects and dysregulated expression of key mitotic kinases. Biochem Pharmacol. 2013;85:1104-14 pubmed publisher